The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Abstract
Two thousand three hundred and thirty two nonselected brains from 1- to 100-year-old individuals were examined using immunocytochemistry (AT8) and Gallyas silver staining for abnormal tau; immunocytochemistry (4G8) and Campbell-Switzer staining were used for the detection ofβ-amyloid. A total of 342 cases was negative in the Gallyas stain but when restaged for AT8 only 10 were immunonegative. Fifty-eight cases had subcortical tau predominantly in the locus coeruleus, but there was no abnormal cortical tau (subcortical Stages a-c). Cortical involvement (abnormal tau in neurites) was identified first in the transentorhinal region (Stage 1a, 38 cases). Transentorhinal pyramidal cells displayed pretangle material (Stage 1b, 236 cases). Pretangles gradually became argyrophilic neurofibrillary tangles (NFTs) that progressed in parallel with NFT Stages I to VI. Pretangles restricted to subcortical sites were seen chiefly at younger ages. Of the total cases, 1,031 (44.2%) had β-amyloid plaques. The first plaques occurred in the neocortex after the onset of tauopathy in the brainstem. Plaques generally developed in the 40s in 4% of all cases, culminating in their tenth decade (75%). β-amyloid plaques and NFTs were significantly correlated (p < 0.0001). These data suggest that tauopathy associated with sporadic Alzheimer disease may begin earlier than previously thought and possibly in the lower brainstem rather than in the transentorhinal region.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Up to 60% of CU individuals over age 80 years have AD neuropathologic changes at autopsy or by biomarkers [60,152,212–214].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [213]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“screening revealed low rates of Braak 1–2 NFT stages in all three groups (Table 2), consistent with literature-based norms [3].”
From Tuberous sclerosis complex is associated with a novel human tauopathy (2023) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It should be noted that tau aggregation in the brain is associated with older age and is generally uncommon in healthy young adults (Braak et al., 2011; Crary et al., 2014).”
From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Braak et al., 2011
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It is expected that many persons die with brains that exhibit AD neuropathologic change in the preclinical phase of AD; indeed, data support the modeled expectations (44, 142).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“Medial temporal and brainstem neurofibrillary changes were observed in our older TSC subjects, as expected, but at a rate comparable to that observed in the epilepsy and non-neurological control groups and age-based norms [3].”
From Tuberous sclerosis complex is associated with a novel human tauopathy (2023) · cites this paper as [3]
In the citing paper
“In individuals with autosomal dominant mutations in genes coding for amyloid precursor protein (APP) or Presenilin 119 , alterations in Aβ generation that result in early deposition of plaque initiate the disease and patients invariably develop the full spectrum of tau pathology 120,121 .”
From The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics (2022) · cites this paper as [121]
In the citing paper
“NFTs first appear in layer II of the entorhinal cortex (EC) during AD onset.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [231]
In the citing paper
“NFTs subsequently appear in interconnected anatomical regions within the brain, including the hippocampus and neocortex during neurodegenerative progression [229–231].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [231]
In the citing paper
“Furthermore, it impairs adult hippocampal neurogenesis in mice and affects cortical thickness, brain activity, and mitochondrial function well before significant Aβ accumulation in the human brains [74–76].”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [76]
In the citing paper
“Most of all, this binary threshold does not reflect the reality of amyloid β and tau pathology, which is continuous and present at a minimal extent in almost all people older than 70 years,17 with important discrepancies between pathology burden and clinical symptoms at intermediate extents (panel 2).”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [17]
In the citing paper
“For tau biomarkers, there is also a strong discrepancy between neuropathological identification (in post-mortem studies, the presence of tau Braak stages I–II is almost universal after age 70 years)17,19 and in-vivo measures of tau aggregates on PET (36% of individuals are tau positive after the age of 70 years23).”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [17]
In the citing paper
“The concordance of genetics and Aβ deposition is aligned with CPC studies that indicate that AβPs may be a temporally “upstream” feature of the neocortical disease, with the caveats that brainstem and medial temporal lobe pretangles and NFTs are seen in subjects without Aβ deposition in all age categories (33, 39, 44).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
In the citing paper
“In contrast to NFTs, AβPs are extracellular (45, 46) and are found in a high proportion of all elderly persons but are not universal (44, 47, 48).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
In the citing paper
“Recently, it has been reported that NFTs are also very common in certain brainstem nuclei in subjects without dementia (39-44).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
In the citing paper
“Neurofibrillary pathology is observed in the human brain long before Aβ plaques develop (39, 44, 300).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
In the citing paper
“Neuritic plaques seem to develop after diffuse AβPs and NFTs (44).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
In the citing paper
“At 40 years, all individuals studied by Braak and Del Tredici (39) and Braak et al (44) exhibited at least initial neurofibrillary pathology in the brainstem (Fig. 5).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2×
“The first lesions were usually seen in the transentorhinal region (2).”
BackgroundSelf-citationThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Self-citationHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Self-citationBraak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Self-citationA Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,153
The locus coeruleus and noradrenergic modulation of cognition
Sara, S. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2573 · Cited by 1,848
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Self-citation
Cited by
Sorted by citations
Items 701–800 of 1,010
The emotion paradox in the aging body and brain
Mather, M. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15138 · Cited by 38
Spectrum of tau pathologies in Huntington's disease
Baskota, S. U., López, O. L., Greenamyre, J. T., & Kofler, J. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0166-9 · Cited by 38
Quinlan, M. A. L., Strong, V., Skinner, D. M., Martin, G. M., Harley, C. W., & Walling, S. G. (2019) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2018.00067 · Cited by 38
Rhizoma Coptidis for Alzheimer’s Disease and Vascular Dementia: A Literature Review
Wang, Z., Yang, Y., Liu, M., Wei, Y., Liu, J., Pei, H., & Li, H. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190710151545 · Cited by 38
White matter alterations in Alzheimer’s disease without concomitant pathologies
Ferrer, I., & Andrés‐Benito, P. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12618 · Cited by 38
Wu, S. Z., Masurkar, A. V., & Balcer, L. J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.572337 · Cited by 38
Duquette, A., Pernègre, C., Carpentier, A. V., & Leclerc, N. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.607680 · Cited by 38
The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer’s disease
Giorgi, F. S., Galgani, A., Puglisi‐Allegra, S., Busceti, C. L., & Fornai, F. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02338-8 · Cited by 38
Gietl, A. F., Warnock, G., Riese, F., Kälin, A. M., Saake, A., Gruber, E., Leh, S. E., Unschuld, P. G., Kuhn, F. P., Burger, C., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.036 · Cited by 38
Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration
Chatterjee, S., Sealey, M. A., Ruiz, E., Pegasiou, C. M., Brookes, K. J., Green, S., Crisford, A., Duque-Vasquez, M., Luckett, E. S., Robertson, R., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0262792 · Cited by 37
Mesenchymal Stem Cell-Derived Exosomes as a Neuroregeneration Treatment for Alzheimer’s Disease
Shah, S., Mansour, H. M., Aguilar, T. M., & Lucke-Wold, B. P. (2024) · Biomedicines · doi:10.3390/biomedicines12092113 · Cited by 37
mNos2Deletion and HumanNOS2Replacement in Alzheimer Disease Models
Colton, C. A., Wilson, J. G., Everhart, A. L., Wilcock, D. M., Puoliväli, J. T., Heikkinen, T., Oksman, J., Jääskeläinen, O., Lehtimäki, K. K., Laitinen, T., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000094 · Cited by 37
Shimojo, M., Higuchi, M., Suhara, T., & Sahara, N. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00482 · Cited by 37
Biomarkers in Alzheimer’s disease
Janeiro, M. H., Ardanaz, C. G., Sola-Sevilla, N., Dong, J., Cortés-Erice, M., Solas, M., Puerta, E., & Ramírez, M. J. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0090 · Cited by 37
Markovic, S. J., Fitzgerald, M., Peiffer, J. J., Scott, B. R., Rainey‐Smith, S. R., Sohrabi, H. R., & Brown, B. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101322 · Cited by 37
Streit, W. J., Rotter, J., Winter, K., Müller, W. C., Khoshbouei, H., & Bechmann, I. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215334 · Cited by 37
The chaperone Clusterin in neurodegeneration−friend or foe?
Yuste‐Checa, P., Bracher, A., & Hartl, F. U. (2022) · BioEssays · doi:10.1002/bies.202100287 · Cited by 37
Fused Cycloheptatriene–BODIPY Is a High-Performance Near-Infrared Probe to Image Tau Tangles
Xie, T., Li, Y., Tian, C., Yuan, C., Dai, B., Wang, S., Zhou, K., Liu, J., Tan, H., Liang, Y., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00859 · Cited by 37
Walsh, C., Drinkenburg, W. H. I. M., & Ahnaou, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.020 · Cited by 37
Molecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases
Lee, H.-J., Yoon, Y.-S., & Lee, S.-J. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168114 · Cited by 36
Guan, D. X., Rehman, T., Nathan, S., Durrani, R., Potvin, O., Duchesne, S., Pike, G. B., Smith, E. E., & Ismail, Z. (2024) · Human Brain Mapping · doi:10.1002/hbm.70016 · Cited by 36
Ferroptosis and pathogenesis of neuritic plaques in Alzheimer disease
Streit, W. J., Phan, L. T., & Bechmann, I. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000823 · Cited by 36
Gelpí, E., Reinecke, R., Gaig, C., Iranzo, Á., Sabater, L., Molina‐Porcel, L., Aldecoa, I., Endmayr, V., Högl, B., Schmutzhard, E., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02805-y · Cited by 36
Mawanda, F., Wallace, R. B., McCoy, K. D., & Abrams, T. E. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.08.004 · Cited by 36
Adeno‐associated virus‐based Alzheimer's disease mouse models and potential new therapeutic avenues
Ittner, L. M., Klugmann, M., & Ke, Y. D. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14637 · Cited by 36
Diagnosis and treatment of cognitive impairment
Arnim, C. A. F. V., Bartsch, T., Jacobs, A. H., Holbrook, J. A., Bergmann, P., Zieschang, T., Polidori, M. C., & Dodel, R. C. (2019) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-019-01560-0 · Cited by 36
Elman, J. A., Panizzon, M. S., Gustavson, D. E., Franz, C. E., Sanderson‐Cimino, M. E., Lyons, M. J., & Kremen, W. S. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.12.021 · Cited by 36
Glennon, E. B. C., Lau, D. H. W., Gabriele, R. M. C., Taylor, M. F., Troakes, C., Opie-Martin, S., Elliott, C., Killick, R., Hanger, D. P., Perez‐Nievas, B. G., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa011 · Cited by 36
Caselli, R. J., Knopman, D. S., & Bu, G. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12124 · Cited by 36
Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission
Jaunmuktane, Z., Banerjee, G., Paine, S., Parry‐Jones, A., Rudge, P., Grieve, J., Toma, A. K., Farmer, S. F., Mead, S., Houlden, H., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02326-y · Cited by 36
Durairajan, S. S. K., Selvarasu, K., Bera, M. R., Rajaram, K., Iyaswamy, A., & Li, M. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210906125318 · Cited by 36
Chu, W. T., Wang, W., Záborszky, L., Golde, T. E., DeKosky, S. T., Duara, R., Loewenstein, D., Adjouadi, M., Coombes, S. A., & Vaillancourt, D. E. (2021) · Neurology · doi:10.1212/wnl.0000000000013206 · Cited by 36
Walker, A. P., Chapin, B. A., Abisambra, J. F., & DeKosky, S. T. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01311-0 · Cited by 36
Hussain, R., Ullah, H., Khan, S., Khan, Y., Iqbal, T., Iqbal, R., Almoallim, H. S. M., & Ansari, M. J. (2024) · Results in Chemistry · doi:10.1016/j.rechem.2024.101503 · Cited by 36
Du, X., West, M., Cheng, W., Ewert, D. L., Li, W., Saunders, D., Towner, R. A., Floyd, R. A., & Kopke, R. D. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4159357 · Cited by 36
Reply: the early pathological process in sporadic Alzheimer’s disease
Braak, H., & Tredici, K. D. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1170-1 · Cited by 36
Self-citationTauopathy and Epilepsy Comorbidities and Underlying Mechanisms
Hwang, K., Vaknalli, R. N., Addo-Osafo, K., Vicente, M., & Vossel, K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.903973 · Cited by 35
Walker, J. M., Goette, W. F., Farrell, K. W., Iida, M. A., Karlovich, E., The PART Working Group, White, C. L., Crary, J. F., & Richardson, T. E. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12966 · Cited by 35
Woelfle, S., Deshpande, D., Feldengut, S., Braak, H., Tredici, K. D., Roselli, F., Deisseroth, K. A., Michaelis, J., Boeckers, T. M., & Schön, M. (2023) · BMC Biology · doi:10.1186/s12915-023-01582-6 · Cited by 35
Self-citationIannitelli, A. F., & Weinshenker, D. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105287 · Cited by 35
Falgàs, N., Peña‐González, M., Val‐Guardiola, A., Pérez‐Millan, A., Guillén, N., Sarto, J., Esteller, D., Bosch, B., Fernández‐Villullas, G., Tort‐Merino, A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14131 · Cited by 35
Ioannou, K., Bucci, M., Tzortzakakis, A., Savitcheva, I., Nordberg, A. K., Chiotis, K., & Initiative, A. D. N. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02672-9 · Cited by 35
Autophagy and Cellular Senescence in Alzheimer's Disease: Key Drivers of Neurodegeneration
Hussain, M. S., Agrawal, N., Ilma, B., Rekha, M. M., Nayak, P. P., Kaur, M., Khachi, A., Goyal, K., Rekha, A., Gupta, S., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70503 · Cited by 35
Noradrenergic modulation of emotional memory in aging
Mammarella, N., Domenico, A. D., Palumbo, R., & Fairfield, B. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.03.004 · Cited by 35
Localizing Sources of Brain Disease Progression with Network Diffusion Model
Hu, C., Hua, X., Ying, J., Thompson, P. M., Fakhri, G. E., & Li, Q. (2016) · IEEE Journal of Selected Topics in Signal Processing · doi:10.1109/jstsp.2016.2601695 · Cited by 35
Anterior Cingulate Cortex TDP-43 Pathology in Sporadic Amyotrophic Lateral Sclerosis
Braak, H., & Tredici, K. D. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx104 · Cited by 35
Self-citationIf Human Brain Organoids Are the Answer to Understanding Dementia, What Are the Questions?
Ooi, L., Dottori, M., Cook, A. L., Engel, M., Gautam, V., Grubman, A., Hernández, D., King, A. E., Maksour, S., Anastacio, H. T. D., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420912404 · Cited by 35
Centenarians as Models of Resistance and Resilience to Alzheimer’s Disease and Related Dementias
Andersen, S. L. (2020) · Advances in Geriatric Medicine and Research · doi:10.20900/agmr20200018 · Cited by 35
del Cerro, I., Martínez‐Zalacaín, I., Guinea-Izquierdo, A., Gascón‐Bayarri, J., Viñas-Díez, V., Urretavizcaya, M., Naval‐Baudin, P., Aguilera, C., Reñé‐Ramírez, R., Ferrer, I., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102482 · Cited by 35
Association of glial tau pathology and LATE-NC in the ageing brain
Forrest, S. L., Wagner, S., Kim, A., & Kovács, G. G. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.07.010 · Cited by 35
Louis, E. D., Hernandez, D. I., Hernandez, N. C., Flowers, X. E., Kuo, S., Vonsattel, J. P., & Faust, P. L. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac068 · Cited by 35
Alzheimer’s Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline
Vakalopoulos, C. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170364 · Cited by 34
Unifying framework for cognitive training interventions in brain aging
Turnbull, A. G., Seitz, A. R., Tadin, D., & Lin, F. V. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101724 · Cited by 34
The Locus Coeruleus—Noradrenergic System in the Healthy and Diseased Brain: A Narrative Review
Caestecker, S., Lescrauwaet, E., Boon, P., Carrette, E., Raedt, R., & Vonck, K. E. J. (2025) · European Journal of Neurology · doi:10.1111/ene.70337 · Cited by 34
Irmler, M., Gentier, R. J. G., Dennissen, F. J. A., Schulz, H., Bolle, I., Hölter, S. M., Kallnik, M., Cheng, J. J., Klingenspor, M., Rozman, J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1003-7 · Cited by 34
Primary Age-Related Tauopathy: An Elderly Brain Pathology Frequently Encountered during Autopsy
Kim, D., Kim, H.-S., Choi, S., Kim, B. C., Lee, M. C., Lee, K., & Lee, J.-H. (2019) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2019.03.14 · Cited by 34
The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders
Queiroz, S. A. L., Ton, A. M. M., Pereira, T. D. M. C., Campagnaro, B. P., Martinelli, L., Picos, A., Campos‐Toimil, M., & Vasquez, E. C. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.872594 · Cited by 34
The role of nutrition on cognition and brain health in ageing: a targeted approach
Monti, J. M., Moulton, C. J., & Cohen, N. J. (2015) · Nutrition Research Reviews · doi:10.1017/s0954422415000141 · Cited by 34
Lee, S. H., Lutz, D., Mossalam, M., Bolshakov, V. Y., Frotscher, M., & Shen, J. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0189-5 · Cited by 34
Yang, J., Shi, X., Wang, Y., Ma, M., Liu, H., Wang, J., & Xu, Z. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230593 · Cited by 33
Laguna, A., Peñuelas, N., González-Sepúlveda, M., Nicolau, A., Arthaud, S., Guillard-Sirieix, C., Picón, M. L., Compte, J., Miquel-Rio, L., Xicoy, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53168-7 · Cited by 33
Elkotamy, M. S., Elgohary, M. K., Alkabbani, M. A., Hefina, M. M., Tawfik, H. O., Farès, M., Eldehna, W. M., & Abdel‐Aziz, H. A. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117158 · Cited by 33
Zhuang, X., Jie, L., Song, Y., Ban, R., Zhao, X., Xia, Z., Wang, Z., & Zhang, G. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08815-z · Cited by 33
Decisive role of Reelin signaling during early stages of Alzheimer’s disease
Krstic, D., Pfister, S., Notter, T., & Knuesel, I. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.042 · Cited by 33
Jonin, P., Calia, C., Muratot, S., Belliard, S., Duché, Q., Barbeau, E. J., & Parra, M. A. (2018) · Cortex · doi:10.1016/j.cortex.2018.08.011 · Cited by 33
Evidence of corticofugal tau spreading in patients with frontotemporal dementia
Kim, E., Hwang, J., Gaus, S. E., Nana, A. L., Deng, J., Brown, J. A., Spina, S., Lee, M. J., Ramos, E. M., Grinberg, L. T., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02075-z · Cited by 33
Reale, M., Gonzales-Portillo, I., & Borlongan, C. V. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146535 · Cited by 33
Kim, K.-R., Kim, Y., Jeong, H., Kang, J.-S., Lee, S. H., Kim, Y., Lee, S., & Ho, W. (2021) · Molecular Brain · doi:10.1186/s13041-021-00774-x · Cited by 33
Galgani, A., Lombardo, F. P., Martini, N., Vergallo, A., Bastiani, L., Hampel, H. J., Hlavata, H., Baldacci, F., Tognoni, G., Marchi, D. D., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15556 · Cited by 33
Srinivaspura Aging, Neuro Senescence and COGnition (SANSCOG) study: Study protocol
Ravindranath, V., & SANSCOG Study Team (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12722 · Cited by 33
Visual Processing during Short-Term Memory Binding in Mild Alzheimer’s Disease
Fernández, G., Orozco, D., Agamennoni, O. E., Schumacher, M., Sañudo, S., Biondi, J. A., & Parra, M. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170728 · Cited by 33
Missing Puzzle Pieces in Dementia Research: HCN Channels and Theta Oscillations
Kaźmierska, P., Jankowski, M. M., & MacIver, M. B. (2023) · Aging and Disease · doi:10.14336/ad.2023.0607 · Cited by 32
Plasticity of human microglia and brain perivascular macrophages in aging and Alzheimer’s disease
Lee, D., Vicari, J. M., Porras, C., Spencer, C., Pjanic, M., Wang, X., Kinrot, S., Weiler, P., Kosoy, R., Bendl, J. M., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02716-6 · Cited by 32
Multimodal MRI ‐based imputation of the A β + in early mild cognitive impairment
Tosun, D., Joshi, S. C., Weiner, M. W., & Initiative, A. D. N. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.40 · Cited by 32
Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease
Henderson, V. W. (2014) · Climacteric · doi:10.3109/13697137.2014.929650 · Cited by 32
Comparison of Amyloid β and Tau Spread Models in Alzheimer’s Disease
Kim, H., Lee, P., Seo, S. W., Roh, J. H., Oh, M., Oh, J. S., Oh, S. J., Kim, J. S., & Jeong, Y. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy311 · Cited by 32
Lower Locus Coeruleus MRI intensity in patients with late-life major depression
Guinea-Izquierdo, A., Giménez, M., Martínez‐Zalacaín, I., del Cerro, I., Canal-Noguer, P., Blasco, G., Gascón, J., Reñé, R., Rico, I., Camins, À., et al. (2021) · PeerJ · doi:10.7717/peerj.10828 · Cited by 32
Shively, S. B., Priemer, D. S., Stein, M. B., & Perl, D. P. (2021) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2021.04.003 · Cited by 32
Olfaction and Executive Cognitive Performance: A Systematic Review
Ramaswamy, V. M. C., & Schofield, P. W. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.871391 · Cited by 32
A new perspective on Alzheimer’s disease: m6A modification
Xia, L., Zhang, F., Li, Y., Mo, Y., Zhang, L., Li, Q., Luo, M., Hou, X., Du, Z., Deng, J., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1166831 · Cited by 32
Age-, sex-, and pathology-related variability in brain structure and cognition
Bachmann, D., Buchmann, A., Studer, S. T., Saake, A., Rauen, K., Zuber, I., Gruber, E., Nitsch, R. M., Höck, C., Gietl, A. F., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02572-6 · Cited by 32
Green, A. E., Gray, J. R., DeYoung, C. G., Mhyre, T. R., Padilla, R. M., DiBattista, A. M., & Rebeck, G. W. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2013.12.020 · Cited by 32
Teravskis, P. J., Oxnard, B. R., Miller, E. C., Kemper, L. J., Ashe, K. H., & Liao, D. (2019) · The Journal of Physiology · doi:10.1113/jp277459 · Cited by 32
Contador, I., Buch-Vicente, B., del Ser, T., Velasco, S. L., Villarejo‐Galende, A., Benito‐León, J., & Bermejo‐Pareja, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144100 · Cited by 31
O’Sullivan, S., Heinsen, H., Grinberg, L. T., Chimelli, L. M. C., Amaro, E., Saldiva, P. H. N., Jeanquartier, F., Jean-Quartier, C., Martin, M. D. G. M., Sajid, M. I., et al. (2019) · Brain Informatics · doi:10.1186/s40708-019-0096-3 · Cited by 31
Zhang, J., Chen, B., Lu, J., Wu, Y., Wang, S., Yao, Z., Zhu, L., Qiao, Y., Sun, Q., Qin, W., et al. (2019) · Aging Cell · doi:10.1111/acel.12978 · Cited by 33
Jové, M., Mota‐Martorell, N., Torres, P., Ayala, V., Portero‐Otín, M., Ferrer, I., & Pamplona, R. (2021) · Life · doi:10.3390/life11050388 · Cited by 31
Mioni, G., Román-Caballero, R., Clerici, J., & Capizzi, M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113354 · Cited by 31
Fu, Z., Zhao, M., He, Y., Wang, X., Lu, J., Li, S., Li, X., Kang, G., Han, Y., & Li, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.686598 · Cited by 31
Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology
Gouilly, D., Rafiq, M., Nogueira, L., Salabert, A., Payoux, P., Péran, P., & Pariente, J. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.12.006 · Cited by 31
Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain
Bates, K. A., Vink, R., Martins, R. N., & Harvey, A. R. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.020 · Cited by 31
Mar, J., Soto‐Gordoa, M., Arrospide, A., Moreno, F., & Martínez‐Lage, P. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0079-9 · Cited by 31
Wheeler, J. M., McMillan, P. J., Hawk, M., Iba, M., Robinson, L., Xu, G. J., Dombroski, B. A., Jeong, D., Dichter, M. A., Juul, H., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0210-6 · Cited by 31
Tissot, C., Servaes, S., Lussier, F. Z., Ferrari‐Souza, J. P., Therriault, J., Ferreira, P. C. L., Bezgin, G., Bellaver, B., Leffa, D. T., Mathotaarachchi, S. S., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264434 · Cited by 30
Darricau, M., Dou, C., Kinet, R., Zhu, T., Zhou, L., Li, X., Bedel, A., Claverol, S., Tokarski, C., Katsinelos, T., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13604 · Cited by 30
Modulatory effects of noradrenergic and serotonergic signaling pathway on neurovascular coupling
Renden, R., Institóris, Á., Sharma, K., & Tran, C. H. T. (2024) · Communications Biology · doi:10.1038/s42003-024-05996-y · Cited by 30
Cummings, J. L., Brubaker, M., Selzler, K. J., Gonzalez, S. T., Patel, M., & Stahl, S. M. (2024) · CNS Spectrums · doi:10.1017/s1092852924000427 · Cited by 30
Further insights into Alzheimer disease pathogenesis
Weiner, M. W. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.275 · Cited by 30
Retired National Football League Players are Not at Greater Risk for Suicide
Iverson, G. L. (2019) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acz023 · Cited by 30
Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease
Cavedo, E., Lista, S., Houot, M., Vergallo, A., Grothe, M. J., Teipel, S. J., Zetterberg, H., Blennow, K., Habert, M., Potier, M., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008696 · Cited by 30
Metadata
- Authors
- Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Braak, Heiko
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-11
- Volume
- 70
- Issue
- 11
- Pages
- 960-969
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W1993023011
- Cited by
- 2,194
- References
- 75
- Citations by year
- 2026: 152 · 2025: 192 · 2024: 260 · 2023: 233 · 2022: 192 · 2021: 235 · 2020: 182 · 2019: 144 · 2018: 121 · 2017: 110 · 2016: 100 · 2015: 85 · 2014: 78 · 2013: 65 · 2012: 42
- FWCI
- 41.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer Forschung Initiative (10810)
- Deutsche Forschungsgemeinschaft (TH624 4–1)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, pathological staging, tauopathy, neurofibrillary tangles, amyloid plaques, locus coeruleus, brainstem, sporadic Alzheimer's disease, AT8 antibody
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Neurons, Cohort Studies, Amyloid beta-Peptides, Silver Staining, Neurofibrillary Tangles, tau Proteins, Disease Progression, Statistics, Nonparametric, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
